Cambrooke Therapeutics

Cambrooke Therapeutics is committed to providing innovative clinical nutrition products. The company's dietary foods are designed to meet the dietary management needs of individuals with metabolic disorders and kidney diseases, such as Phenylketonuria (PKU), a rare condition in infants who cannot break down the amino acid phenylalanine, enabling patients to receive effective treatment while maintaining their normal daily lives.